BIRNDORF HOWARD C 4
4 · NANOGEN INC · Filed Mar 2, 2005
Insider Transaction Report
Form 4
NANOGEN INCNGEN
BIRNDORF HOWARD C
DirectorExecutive Chairman and CEO
Transactions
- Sale
Common Stock
2005-03-01$4.00/sh−10,000$40,000→ 665,552 total - Sale
Common Stock
2005-03-01$4.03/sh−5,000$20,150→ 685,552 total
Holdings
- 400,000
Non-Qualified Stock Option
Exercise: $1.90Exp: 2012-07-26→ Common Stock (400,000 underlying) - 70,000
Non-Qualified Stock Option
Exercise: $6.00Exp: 2011-07-27→ Common Stock (70,000 underlying) - 127,306
Non-Qualified Stock Option
Exercise: $5.11Exp: 2012-01-25→ Common Stock (127,306 underlying) - 325,000
Non-Qualified Stock Option
Exercise: $3.45From: 2004-01-18Exp: 2013-07-18→ Common Stock (325,000 underlying) - 282,122
Non-Qualified Stock Option
Exercise: $4.70From: 2005-01-29Exp: 2014-07-29→ Common Stock (282,122 underlying) - 17,878
Incentive Stock Option
Exercise: $4.70From: 2005-01-29Exp: 2014-07-29→ Common Stock (17,878 underlying) - 22,694
Incentive Stock Option
Exercise: $5.11Exp: 2012-01-25→ Common Stock (22,694 underlying) - 80,000
Non-Qualified Stock Option
Exercise: $11.94Exp: 2011-01-26→ Common Stock (80,000 underlying) - 25,000
Incentive Stock Option
Exercise: $4.50Exp: 2009-01-22→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 selling plan adopted by Howard Birndorf on February 23, 2004.
- [F2]Various exercise dates for previously reported holding.